Feb 5 (Reuters) - Drug distributor Cencora (COR.N), opens new tab raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines. The Conshohocken ...

The company disclosed the sale of 1,087,885 shares of Cencora common stock, valued at approximately $264.5 million, at a price of $244.51 per share. Additionally, a private transaction sale of ...

Shares of Cencora (COR) have been strong performers lately, with the stock up 13.4% over the past month. The stock hit a new 52-week high of $256.81 in the previous session. Cencora has gained 13. ...

As part of its commitment to address the issue, Cencora continues to partner with stakeholders across the industry – including public and private sectors – to advance solutions designed to ...

Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said ...